These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1253882)

  • 1. Schistosoma mansoni: reduction in clinical manifestations and in worm burdens conferred by serum and transfer factor from immune or normal rhesus monkeys.
    Maddison SE; Hicklin MD; Kagan IG
    Exp Parasitol; 1976 Feb; 39(1):29-39. PubMed ID: 1253882
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization against Schistosoma mansoni in rhesus monkeys and the requirement of activation of both cell-mediated and humoral mechanisms.
    Maddison SE; Kagan IG; Chandler FW; Gold D; Hillyer GV; Slemenda SB; Tsang V
    Infect Immun; 1979 Jul; 25(1):237-48. PubMed ID: 113342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunology of schistosomiasis.
    Smithers SR; Terry RJ
    Adv Parasitol; 1976; 14():399-422. PubMed ID: 816180
    [No Abstract]   [Full Text] [Related]  

  • 4. Immediate, Arthus, and delayed-type skin reactions in rhesus monkeys infected with Schistosoma mansoni or mycobacteria.
    Maddison SE; Hicklin MD; Kagan IG
    J Allergy Clin Immunol; 1973 Sep; 52(3):131-40. PubMed ID: 4269339
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypersensitivity to parasite proteolytic enzyme in schistosomiasis.
    Senft AW; Maddison SE
    Am J Trop Med Hyg; 1975 Jan; 24(1):83-9. PubMed ID: 1111360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer factor: delayed hypersensitivity to Schistosoma mansoni and tuberculin in Macaca mulatta.
    Maddison SE; Hicklin MD; Conway BP; Kagan IG
    Science; 1972 Nov; 178(4062):757-9. PubMed ID: 4628344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunizing efficacy of a Kenyan strain of Schistosoma mansoni in rhesus monkeys (Macaca mulatta).
    Damian RT; Greene ND; Meyer KF
    Am J Trop Med Hyg; 1976 Mar; 25(2):355-7. PubMed ID: 816221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of granulomatous and elicitation of cutaneous sensitivity by partially purified SEA of Schistosoma mansoni.
    Boros DL; Tomford R; Warren KS
    J Immunol; 1977 Jan; 118(1):373-6. PubMed ID: 556621
    [No Abstract]   [Full Text] [Related]  

  • 9. Schistosoma japonicum: highly irradiated cercariae as a test for specific immunity in rhesus monkeys.
    Li Hsü SY; Hsü HF; Penick GD; Lust GL; Eveland LK
    Exp Parasitol; 1977 Oct; 43(1):189-95. PubMed ID: 408169
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypersensitivity in human schistosomiasis due to Schistosoma mansoni and Schistosoma haematobium. II. In vitro study of the lethal activity of patient sera for schistosomules of S. mansoni. Relation to hypersensitivity tests].
    Capron A; Capron M; Camus D; Vernes A
    Pathol Biol (Paris); 1973 Dec; 21(10):1079-84. PubMed ID: 4589580
    [No Abstract]   [Full Text] [Related]  

  • 11. The physiobiology and pathogenesis of human schistosomiasis.
    Mousa AH
    Egypt J Bilharz; 1975; 2(2):137-49. PubMed ID: 799573
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed hypersensitivity to specific antigen and hetrologous PPD antigen in patients infected with Schistosoma mansoni and/or Schistosoma haematobium.
    el-Kalouby AH; Amer R; Abdel-Wahab MF; el-Raziky EH
    Egypt J Bilharz; 1979; 6(1-2):43-9. PubMed ID: 263096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer of acquired resistance to Schistosoma mansoni in laboratory mice.
    Sher A; Smithers SR; Mackenzie P
    Parasitology; 1975 Jun; 70 Part 3():347-57. PubMed ID: 1134831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations on therapeutic and prophylatic effects by homologous immune blood against Schistosoma mansoni in Rhesus monkeys.
    MEISENHELDER JE; OLSZEWSKI B; THOMPSON PE
    J Parasitol; 1960 Oct; 46():645-7. PubMed ID: 13769095
    [No Abstract]   [Full Text] [Related]  

  • 15. The activity of a benzothiopyranoindazole (IA-4 N-oxide) against Schistosoma mansoni infection in rhesus monkeys.
    Reid WA; Loizeaux PS; Reardon MJ
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):937-43. PubMed ID: 410318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to Schistosoma mansoni in rhesus monkeys with multiple chronic and early primary infections.
    Maddison SE; Slemenda SB; Hillyer GV; Chandler FW; Kagan IG
    Infect Immun; 1979 Jul; 25(1):249-54. PubMed ID: 113343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosoma mansoni: reduced worm burdens in mice immunized with isolated Fasciola hepatica antigens.
    Hillyer GV
    Exp Parasitol; 1979 Oct; 48(2):287-95. PubMed ID: 477818
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of immediate and delayed hypersensitivity skin tests with Schistosoma mansoni adult worm antigen in a rural Egyptian population.
    Higashi GI; El-Asfahani AM; El-Bolkainy MN; Chu EW; Raafat M
    Trop Geogr Med; 1980 Sep; 32(3):245-50. PubMed ID: 7210159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of immune rhesus monkey serum on schistosomula of Schistosoma mansoni during cultivation in vitro.
    Clegg JA; Smithers SR
    Int J Parasitol; 1972 Mar; 2(1):79-98. PubMed ID: 4631607
    [No Abstract]   [Full Text] [Related]  

  • 20. Schistosoma mansoni: in vitro and in vivo killing of antibody-coated schistosomula.
    Correa-Oliveira R; Mota-Santos TA; Gazzinelli G
    Am J Trop Med Hyg; 1982 Sep; 31(5):991-8. PubMed ID: 7125066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.